Chemotherapy: Open Access
Open Access

Luca Arcaini

Biography

Luca Arcaini is Assistant Professor of Hematology at University of Pavia School of Medicine, Pavia, Italy and is Attending Physician of Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia. He is in charge of clinical research programs and experimental protocols for indolent non-Hodgkin’s lymphomas.

Research Interest

His research is the focused on the definition of the relationship among lymphoma and hepatitis C virus chronic infection, with collaborative and autonomous studies and in clinico-pathological, biological and prognostic characterization of novel clinical entities, in particular marginal zone-related neoplasms. Luca Arcaini chaired a national project entitled Margianl zone Project (2003-2006). This project collected the largest series of splenic marginal zone patients publishes so far (Blood 2006) and permitted to develop a prognostic score for clinical use. His research activity is also aimed to experimentation of novel modalities of treatments combining anti-CD20 monoclonal antibody and chemotherapy (immunochemotherapy) with an original  clinical and pharmacokinetic model of immunochemotherapy, in vivo purging and lymphoma-free peripheral progenitors cells.